Saturday 17 October 2026
Export DARE’s income statement to Excel — free account
Dare Bioscience, Inc.
DARE Healthcare Biotechnology
Dare Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, up 10,412.2% from fiscal 2024. In the quarter to June 2026, revenue grew 984.4%, EPS grew 55.6% and free cash flow fell 30.2%, each against the same quarter a year earlier.
0.72
0.02
−2.70%
Follow DARE
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | 4 | 4 | — |
| (2,543.18%) | 845.52% | 272.28% | 165.29% | ||
| (71.56%) | (49.10%) | (51.76%) | (62.16%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(320.73%) | (271.40%) | (604.34%) | (928.44%) | |
Average Days of Receivables |
(2,360.03) | 203.05 | 216.92 | 121.95 | |
Free Cash Flow per Share |
(0.53) | (0.92) | (0.68) | (0.78) | |
Free Cash Flow |
(6.77) | (10.27) | (9.94) | (11.60) | |
Capital Expenditures |
(0.74) | (0.39) | — | (0.31) | |
| Other line items | |||||
Cash ROIC |
(25.92%) | (37.28%) | (51.60%) | (96.22%) | |
Accounts Receivable Turnover |
(0.13) | 2.57 | 2.92 | 4.24 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.17 | 0.46 | |
Inventory Turnover |
— | — | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 1,696.95 | 479.19 | |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
(14,426.44%) | 536.15% | 335.82% | 197.64% | |
Selling, General and Administrative Expense of Revenue |
(16,081.26%) | 850.65% | 751.99% | 652.90% | |
Share Based Compensation of Revenue |
(2,852.36%) | 145.27% | 136.03% | 109.95% | |
Operating CF/Net income |
0.34 | 0.74 | 0.83 | 1.03 | |
Depreciation/Fixed assets |
0.74 | 1.05 | 1.39 | 1.50 | |
Capex/Depreciation |
(0.61) | (0.24) | 0.00 | (0.14) | |
Revenue per Share |
0.00 | 0.09 | 0.08 | 0.09 | |
Operating CF per Share |
(0.47) | (0.88) | (0.68) | (0.76) | |
Capex per Share |
(0.06) | (0.03) | 0.00 | (0.02) | |
Capex to Sales |
(12.98) | 0.37 | 0.00 | 0.23 |
Columns are period end dates